Why enVVeno Medical Corporation’s (NVNO) Stock Is Down 71.11%
As of Wednesday, August 20, enVVeno Medical Corporation’s NVNO share price has dipped by 71.11%, which has investors questioning if this is right time to buy.Jenna Brashear
Stock Evaluator: enVVeno Medical Corporation (NVNO)
enVVeno Medical Corporation NVNO
$10.60
-0.03
-0.25%
July 31, 2026 3:46:12 PM
EST
Volume: 2,338
After Hours: $120.37
0.15
|
0.12%
November 10, 2021 7:59 PM
EST
Volume: 72,713
USD
NASD | DELAYED PRICE
| SECTOR | INDUSTRY |
| Health Care | Health Care Equipment & Supplies |
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
enVVeno Medical Corporation, a medical device company, focuses on the development of bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous disease in the United States. The company’s lead product is the VenoValve, a surgical replacement venous valve for the treatment of venous chronic venous insufficiency. Its VenoValve implanted into the femoral vein of the patient in an open surgical procedure via a 5-to-6-inch incision in the upper thigh. The company also develops enVVe, a non-surgical and transcatheter-based replacement venous valve system consisting of the enVVe valve, enVVe delivery system, and delivery system accessories. The company was formerly known as Hancock Jaffe Laboratories, Inc. and changed its name to enVVeno Medical Corporation in October 2021. enVVeno Medical Corporation was incorporated in 1999 and is based in Irvine, California.
Commentary & Analysis
Why enVVeno Medical Corporation’s (NVNO) Stock Is Down 5.38%
As of Friday, July 25, enVVeno Medical Corporation’s NVNO share price has dipped by 5.38%, which has investors questioning if this is right time to buy.Cynthia McLaughlin
Why enVVeno Medical Corporation’s (NVNO) Stock Is Down 6.86%
As of Friday, July 18, enVVeno Medical Corporation’s NVNO share price has dipped by 6.86%, which has investors questioning if this is right time to buy.Jenna Brashear
Why enVVeno Medical Corporation’s (NVNO) Stock Is Up 5.20%
As of Wednesday, June 11, enVVeno Medical Corporation’s NVNO share price has surged by 5.20%, which has investors questioning if this is right time to sell.Jenna Brashear
Why enVVeno Medical Corporation’s (NVNO) Stock Is Down 5.64%
As of Tuesday, June 10, enVVeno Medical Corporation’s NVNO share price has dipped by 5.64%, which has investors questioning if this is right time to buy.Jenna Brashear
Financial Summary
| Share Statistics | NVNO | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $7.1 | $337.2 | 5% |
|
| Shares Out (Mil) | 0.7 | 41.9 | 3% |
|
| Institutional Ownership | 44.2% | 77.8% | 19% |
|
| Float (Mil) | 0.5 | 34.7 | 1% |
|
| Beta | na | 0.85 | na |
|
| Avg Daily Volume (000s) | 23 | 278 | 22% |
|
| Price Change (52-week) |
(94.1%) | 58.7% | 3% |
|
| Growth | NVNO | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | na | 11.8% | na |
|
| Net Income (5yr) | (16.5%) | (5.8%) | 24% |
|
| EPS (5yr) | 34.0% | 11.4% | 84 |
|
| Dividends (5yr) | na | 0.0% | na |
|
| Cash Flow (5yr) | (59.1%) | (16.3%) | 4% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | na | na | na | |
| Current EPS | na | na | na | |
| Month Ago EPS | na | na | na | |
| # Rev Up | na | na | na | |
| # Rev Down | na | na | na | |
| Three Months Ago EPS | na | na | na | |
| Year/Year Chg | na | na | na | |
| Financials | NVNO | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | na | $152 | na |
|
| Net Income (TTM) (Mil) | ($16) | ($10) | 26% |
|
| EPS (TTM) | ($24.899) | ($0.500) | 2% |
|
| Operating Cash Flow (TTM) (Mil) | ($15) | ($2) | 17% |
|
| Net Cash Flow (TTM) (Mil) | na | $1 | na |
|
| Long-Term Debt (Q1) (Mil) | $0 | $22 | 10% |
|
| Enterprise Value (Q1) (Mil) | ($14) | $304 | 2% |
|
| Valuation | NVNO | Industry Median |
Percentile (All Stocks) |
|
| P/B | 0.35 | 2.80 | 6% |
|
| P/E | na | 31.1 | na |
|
| Dividend Yield | na | 0.0% | na |
|
| PEG (5yr hist) | na | 1.9 | na |
|
| Ratios | NVNO | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | na | 59.1% | na |
|
| Net Margin | na | (7.3%) | na |
|
| ROA | (53.1%) | (13.7%) | 11% |
|
| ROE | (58.5%) | (15.8%) | 14% |
|
| Liabilities to Assets | 8.8% | 44.7% | 5% |
|
| F-Score | 3 | 4 | 19% |
|
enVVeno Medical Corporation did not pass any screens on 7/31/2026.
